| Alivus Life Sciences Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 543322 |
NSE Symbol : ALIVUS |
P/E(TTM) : 26.09 |
|
ISIN Demat : INE03Q201024 |
Div & Yield% : 0.38 |
EPS(TTM) : 50.64 |
|
Book Value(₹) : 271.41 |
Market Cap(₹Cr) : 16,223.02 |
Face Value(₹) : 2.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Gross Sales | 640.41 | 689.12 | 672.89 | 587.98 | 601.85 | 649.55 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 640.41 | 689.12 | 672.89 | 587.98 | 601.85 | 649.55 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 22.40 | 22.78 | 13.93 | 14.72 | 8.99 | 10.09 |
| Total Income | 662.82 | 711.90 | 686.82 | 602.70 | 610.83 | 659.63 |
| Total Expenditure | 428.70 | 474.59 | 467.27 | 408.81 | 429.54 | 451.11 |
| PBIDT | 234.12 | 237.31 | 219.54 | 193.89 | 181.30 | 208.52 |
| Interest | 1.31 | 1.31 | 1.49 | 1.32 | 1.25 | 1.26 |
| PBDT | 232.81 | 236.00 | 218.05 | 192.57 | 180.05 | 207.26 |
| Depreciation | 20.59 | 20.20 | 19.66 | 18.44 | 17.06 | 15.97 |
| Tax | 50.27 | 51.09 | 53.92 | 39.95 | 38.94 | 47.88 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 1.87 | 2.05 | -5.79 | 4.16 | 2.51 | 1.55 |
| Reported Profit After Tax | 160.08 | 162.66 | 150.26 | 130.03 | 121.54 | 141.87 |
| Extra-ordinary Items | 0.00 | 0.00 | -18.68 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 160.08 | 162.66 | 168.94 | 130.03 | 121.54 | 141.87 |
| EPS (Unit Curr.) | 13.04 | 13.23 | 12.25 | 10.60 | 9.91 | 11.57 |
| EPS (Adj) (Unit Curr.) | 13.04 | 13.23 | 12.25 | 10.60 | 9.91 | 11.57 |
| Calculated EPS (Unit Curr.) | 13.04 | 13.25 | 12.25 | 10.22 | 9.91 | 11.58 |
| Calculated EPS (Adj) (Unit Curr.) | 13.04 | 13.25 | 12.25 | 10.22 | 9.91 | 11.58 |
| Calculated EPS (Ann.) (Unit Curr.) | 52.17 | 53.01 | 48.99 | 40.90 | 39.64 | 46.31 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 52.17 | 53.01 | 48.99 | 40.90 | 39.64 | 46.31 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 24.55 | 24.55 | 24.54 | 25.44 | 24.53 | 24.51 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 36.56 | 34.44 | 32.63 | 32.98 | 30.12 | 32.10 |
| PBDTM(%) | 36.35 | 34.25 | 32.40 | 32.75 | 29.92 | 31.91 |
| PATM(%) | 25.00 | 23.60 | 22.33 | 22.11 | 20.19 | 21.84 |
